Study of a Mobile Digital Support Program to Help Women With Breast Cancer Take Their Hormone Treatment and Manage Symptoms

What this Trial Is About

Researchers are evaluating the effect of Sidekick Healths digital program on self-efficacy and medication adherence in women diagnosed with breast cancer who are prescribed adjuvant anti-hormonal treatment. This randomized, controlled trial compares the digital patient support program plus standard of care with standard of care alone. The study aims to support breast cancer patients in managing symptoms and improving medication adherence during their endocrine treatment. Participants are randomly assigned to one of two groups one group uses the Sidekick Health app alongside their standard breast cancer treatment, while the other group receives only the standard care. The digital program includes a medication center with behavioral change materials, gamification, rewards, and engaging tasks to promote self-efficacy and healthy lifestyle changes. Both groups receive the usual adjuvant treatment and any optional cancer rehabilitation not delivered through an app. Throughout the study, participants will be monitored for their self-efficacy and medication adherence at 12 weeks, 24 weeks, and one year. Researchers will collect data on medication persistence, physical activity, body mass index, symptom management, quality of life, and user satisfaction with the app. The study includes follow-up assessments up to five years to evaluate adherence and long-term outcomes. Participants will complete questionnaires and in-app reports, and their engagement with the digital program will be tracked.

Digital Patient Support Program for Self-efficacy and Medication Adherence in Women on Adjuvant Endocrine Treatment for Breast Cancer